Portable-electronic device
Latest Novartis AG Patents:
- Tricyclic AKR1C3 dependent KARS inhibitors
- Treatment of cancer using GFR alpha-4 chimeric antigen receptor
- Methods of treating HIV-HAART induced partial lipodystrophy with FGF21 protein variant FC fusion proteins
- Solid forms comprising an oxime ether compound, compositions and methods of use thereof
- Urea compounds and compositions as SMARCA2/BRM ATPase inhibitors
Description
The broken lines represent boundaries or environmental features, and form no part of the claimed design.
Claims
The ornamental design for a portable-electronic device, as shown and described.
Referenced Cited
Patent History
Patent number: D616993
Type: Grant
Filed: Mar 13, 2009
Date of Patent: Jun 1, 2010
Assignee: Novartis AG (Basel)
Inventors: Jan Muis (Utrecht), Lukas Fransen (Middelburg), Rutger Alexander Brest van Kempen (Noord Scharwoude), Alexander Adriaan Huntelerslag (Zuld-Scharwoude)
Primary Examiner: Lisa P Lichtenstein
Attorney: Montgomery, McCracken, Walker & Rhoads, LLP
Application Number: 29/333,688
Type: Grant
Filed: Mar 13, 2009
Date of Patent: Jun 1, 2010
Assignee: Novartis AG (Basel)
Inventors: Jan Muis (Utrecht), Lukas Fransen (Middelburg), Rutger Alexander Brest van Kempen (Noord Scharwoude), Alexander Adriaan Huntelerslag (Zuld-Scharwoude)
Primary Examiner: Lisa P Lichtenstein
Attorney: Montgomery, McCracken, Walker & Rhoads, LLP
Application Number: 29/333,688
Classifications
Current U.S. Class:
Patient Monitor Or Diagnostic Instrument Not Elsewhere Specified (50) (D24/186)